CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled, Phase III Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) Sustained-Release as Monotherapy in Adult Patients With Acute Bipolar Mania

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00422123
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:34:56.224638+00:00
Published At: 2009-03-25T00:00:00+00:00
Record Updated At: 2009-03-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Affective Psychosis, Bipolar", "Manic Disorder", "Manic-Depressive Psychosis", "Mania", "Manic State", "Psychoses, Manic-Depressive"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2009-03-25"
protocolSection.identificationModule.nctId: "NCT00422123"
protocolSection.identificationModule.officialTitle: "A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled, Phase III Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL\u00ae) Sustained-Release as Monotherapy in Adult Patients With Acute Bipolar Mania"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.